References
- JemalABrayFCenterMMGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- AltekruseSFMcGlynnKAReichmanMEHepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005J Clin Oncol20092791485149119224838
- AlvesRCAlvesDGuzBAdvanced hepatocellular carcinoma. Review of targeted molecular drugsAnn Hepatol2011101212721301005
- LencioniRChemoembolization for hepatocellular carcinomaSemin Oncol201239450350922846867
- BruixJLlovetJMPrognostic prediction and treatment strategy in hepatocellular carcinomaHepatology200235351952411870363
- PortaCPaglinoCMedical treatment of unresectable hepatocellular carcinoma: going beyond sorafenibWorld J Hepatol20102310311321160981
- MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer therapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SmancsCancer Res198646638763922946403
- MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzym Regul2001411189207
- CabralHNishiyamaNKataokaKSupramolecular nanodevices: from design validation to theranostic nanomedicineAcc Chem Res20114410999100821755933
- NishiyamaNKataokaKCurrent state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene deliveryPharmacol Ther2006112363064816815554
- KataokaKHaradaANagasakiYBlock copolymer micelles for drug delivery: design, characterization and biological significanceAdv Drug Deliv Rev200147111313111251249
- TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
- DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer20066968870116900224
- DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
- Kukowska-LatalloJFCandidoKACaoZNanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res200565125317532415958579
- LeeCCMacKayJAFrechetJMJSzokaFCDesigning dendrimers for biological applicationsNat Biotech2005231215171526
- KaidaSCabralHKumagaiMVisible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor modelCancer Res201070187031704120685894
- CabralHMurakamiMHojoHTargeted therapy of spontaneous murine pancreatic tumors by polymeric micelles prolongs survival and prevents peritoneal metastasisProc Natl Acad Sci U S A201311028113971140223801758
- SezginZYükselNBaykaraTPreparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugsEur J Pharm Biopharm200664326126816884896
- TrubetskoyVSPolymeric micelles as carriers of diagnostic agentsAdv Drug Deliv Rev1999371–3818810837728
- RapoportNPhysical stimuli-responsive polymeric micelles for anticancer drug deliveryProg Polymer Sci2007328–9962990
- MatsumuraYHamaguchiTUraTPhase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicinBr J Cancer200491101775178115477860
- MatsumuraYPreclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effectAdv Drug Deliv Rev201163318419220561951
- PlummerRWilsonRHCalvertHA Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumoursBr J Cancer2011104459359821285987
- KatoKChinKYoshikawaTPhase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancerInvestig New Drugs20123041621162721728023
- YokoyamaMClinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumorsJ Exp Clin Med201134151158
- YoshikawaMSaishoHEbaraMA randomized trial of intra-hepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinomaCancer Chemother Pharmacol1994331S149S1528137478
- XiaoYHongHJavadiAMultifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imagingBiomaterials201233113071308222281424
- NasongklaNBeyERenJMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systemsNano Lett20066112427243017090068
- MurakamiMCabralHMatsumotoYImproving drug potency and efficacy by nanocarrier-mediated subcellular targetingSci Transl Med201136464ra2
- CabralHNishiyamaNOkazakiSKoyamaHKataokaKPreparation and biological properties of dichloro(1,2-diaminocyclohexane) platinum(II) (DACHPt)-loaded polymeric micellesJ Control Release20051011–322323215588907
- GouinSWinnikFMQuantitative assays of the amount of diethylen-etriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetryBioconjug Chem200112337237711353534
- KishimotoSNoguchiTYamamotoTFukushimaSTakeuchiYAntitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-groing rat hepatic tumor after intra-hepatic arterial administrationBiol Pharm Bull200023334434810726891
- DigumarthySRSahaniDVSainiSMRI in detection of hepatocellular carcinoma (HCC)Cancer Imaging200551202416154814
- MoranaGSalviatoEGuariseAContrast agents for hepatic MRICancer Imaging200772427
- BologNAndreisekGOanceaIMangrauACT and MR imaging of hepatocellular carcinomaJ Gastrointestin Liver Dis201120218118921725516
- CabralHMatsumotoYMizunoKAccumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNat Nano2011612815823
- RafiMCabralHKanoMRPolymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasisJ Control Release2012159218919622326402
- KonnoTMaedaHIwaiKEffect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEur J Cancer Clin Oncol1983198105310656311559
- KanematsuTInokuchiKSugimachiKSelective effects of lipiodolized antitumor agentsJ Surg Oncol19842532182266199624
- BruixJSalaMLlovetJMChemoembolization for hepatocellular carcinomaGastroenterology20041275S179S18815508083
- HanadaMBabaATsutsumishitaYIntra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosisCancer Chemother Pharmacol200964347348319104812
- LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology200337242944212540794